Stockreport

Premier’s ProvideGx™ Program to Make the First FDA-Approved Version of Cysteine Hydrochloride Available to Providers

Premier, Inc. - Class A  (PINC) 
Last premier, inc. - class a earnings: 2/4 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.premierinc.com/overview/default.aspx
PDF CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier Inc. (NASDAQ: PINC), through its ProvideGx™ program, is now supplying cysteine hydrochloride injection to providers, a crit [Read more]